Evaluation of Resection Techniques for Pancreatic Tumors
1 other identifier
observational
431
1 country
1
Brief Summary
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2016
CompletedFirst Submitted
Initial submission to the registry
August 12, 2019
CompletedFirst Posted
Study publicly available on registry
November 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 26, 2027
March 20, 2026
March 1, 2026
11 years
August 12, 2019
March 18, 2026
Conditions
Outcome Measures
Primary Outcomes (7)
Patient Survival
It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
through study completion, an average of 1 year
Length of stay
It will be calculated in days. The days stayed in hospital post-procedure.
Up to 1 year
Complication rates
Patient may visit physician or hospital for any symptoms or may need hospitalizations.
through study completion, an average of 1 year
Operative time
The time required for the procedure.
up to 10 hours
Transfusion rate
If any post-procedure transfusion required, will be recorded.
through study completion, an average of 1 year
30 and 90 day readmission rate
After the procedure any hospital admissions up to 30 days will be recorded.
through study completion, an average of 1 year
Hospital charges
The hospital charges for the procedure will be recorded.
through study completion, an average of 1 year
Interventions
to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint
Eligibility Criteria
pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
You may qualify if:
- Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
- Patients 18 years old or older
You may not qualify if:
- Patients that have not undergone pancreatic resection surgeries
- Patients under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alejandro Mejia, M.D.
The Liver Institute, Methodist Dallas Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2019
First Posted
November 22, 2021
Study Start
April 16, 2016
Primary Completion (Estimated)
April 26, 2027
Study Completion (Estimated)
April 26, 2027
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share